CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

By Gene by Gene

CXO Talks: Josh Wittner from Gene By Gene in a Riveting Conversation with PharmaShots

In this captivating episode of the CXO Talks Podcast, PharmaShots sits down with Josh Wittner, President, North America at Gene By Gene, to explore the company’s evolution and impact in the field of genetic testing

Contact us for Media Inquires

Thank you!

Your submission has been received. Our laboratory will be in touch soon to follow up your enquiry.

An error occurred while submitting the form. Please try again. If the issue persists, please contact our support team.

More Gene by Gene Company News

Acceleration in Genetic Testing Drives Pace of Precision Medicine

Acceleration in Genetic Testing Drives Pace of Precision Medicine

Interview of Lior Rauchberger, CEO of Gene by Gene and myDNA

Must-Listen Interview: Lior Rauchberger on the Future of Digital Health & Personalized Medicine!

Must-Listen Interview: Lior Rauchberger on the Future of Digital Health & Personalized Medicine!

Excited to share this interview with our CEO, Lior Rauchberger, providing insights into the rapidly evolving healthcare landscape.

Our CEO, Lior Rauchberger, on How Whole Genome Sequencing is Revolutionizing Genealogy and Healthcare.

Our CEO, Lior Rauchberger, on How Whole Genome Sequencing is Revolutionizing Genealogy and Healthcare.

Boombostic Health sits down with Gene by Gene CEO, Lior Rauchberger

MyHeritage Upgrades its Consumer DNA Tests to Gene by Gene's Whole Genome Sequencing

MyHeritage Upgrades its Consumer DNA Tests to Gene by Gene's Whole Genome Sequencing

MyHeritage becomes the first major DNA testing company to fully adopt Whole Genome Sequencing; the upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab

Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform

Ultima Genomics and Gene by Gene Partner to Expand Global Access to High-Quality, Low-Cost Sequencing on the UG 100™ Platform

Collaboration Extends Global Reach of High-Performance Genomic Sequencing on the UG 100™ Platform